内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Gengos Andrew. Insider active across 3 companies, notably Athira Pharma, Inc.. Cumulatively, 14 disclosures have been logged. Breakdown: 10 buys · 0 sell. Total volume traded: €213k. Activity tracked since 2 June 2023. The latest transaction was filed on 14 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Gengos Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
68,750 股0Common StockSEC:0001563623-26-000002:0
10,000 股0Common StockSEC:0001104659-25-098567:0
5,000 股@ US$3.926751.0% 占其流量Common StockSEC:0001562180-25-005120:0
5,000 股@ US$3.75100.0% 占其流量Common StockSEC:0001562180-25-004866:0
5,000 股0Common StockSEC:0001415889-24-004149:0
5,000 股0Common StockSEC:0001209191-24-001153:0
422 股@ US$3.35760.7% 占其流量Common StockSEC:0001209191-23-035951:0
10,012 股@ US$2.7514.2% 占其流量Common StockSEC:0001209191-23-034887:0
6,582 股@ US$2.85989.7% 占其流量Common StockSEC:0001209191-23-034887:1
3,418 股@ US$2.9455.2% 占其流量Common StockSEC:0001209191-23-034887:2
15,000 股@ US$3.0023.3% 占其流量Common StockSEC:0001209191-23-034887:3
10,000 股@ US$2.999715.6% 占其流量Common StockSEC:0001209191-23-034887:4
10,000 股@ US$2.999915.6% 占其流量Common StockSEC:0001209191-23-034887:5
10,000 股@ US$3.015415.6% 占其流量Common StockSEC:0001209191-23-034887:6
About Gengos Andrew
Gengos Andrew is CFO AND CHIEF BUSINESS OFFICER at Athira Pharma, Inc. The declarant has 10 filings in total, and across the sampled recent filings from 2023-06-06 to 2024-02-16, the transactions are acquisitions for a total of EUR 179926 and no sales are indicated.